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INTRODUCTION
Kikuchi’s disease is a benign, self-limited disease with well-
defined clinical entity that typically involves the cervical lymph
nodes of adolescents and young adults and occurs commonly
in Asian (1). Hemophagocytic syndrome is a histiocytic reac-
tive process of strong immunologic activation, such as severe
infection, malignancy, autoimmune diseases, and metabolic
diseases (2). It is characterized by histiocytic proliferation,
hemophagocytosis, fever, hepatosplenomegaly, generalized
lymphadenopathy, hypertriglyceridemia, and hypofibrino-
genemia. 
There are eight cases of hemophagocytic syndrome simul-
taneously associated with Kikuchi’s disease in the literature
(3-9). The prognosis and treatment for hemophagocytic syn-
drome in Kikuchi’s disease is still unknown. We report a case
of a 13-yr old girl with simultaneous Kikuchi’s disease and
hemophagocytic syndrome.
CASE REPORT
A 13-yr-old girl was admitted to our hospital because of a
4-week history of fever, generalized maculopapular rash, pro-
gressive cervical lymph node swelling, and an attack of gen-
eralized tonic-clonic seizure 2 days before admission. On exam-
ination, she had a temperature of 38℃ and submandibular
lymphadenopathy (3 to 4 cm in diameter). The liver and spleen
were not palpable. She developed progressive pancytopenia
(white blood cell count, 1,500/ L; hemoglobin 10.3 g/dL;
platelets 39,000/ L). Hepatic dysfunction (AST 1156 IU/L
and ALT 657 IU/L), cholestasis (total bilirubin 2.47 mg/dL
and direct bilirubin 1.88 mg/dL) and acute renal failure (blood
urea nitrogen 18.15 mg/dL, creatinine 1.96 mg/dL) were pre-
sent. Prothrombin time and international normalized ratio
were normal and activated partial thromboplastin time was
mildly prolonged (64.1 sec). Her triglycerides and ferritin lev-
els were increased to 144 mg/dL (normal range, 37-134 mg/
dL) and 14,955.2 ng/mL (normal range, 6-282 ng/dL), respec-
tively. Antinuclear antibody, anti-double stranded DNA anti-
body, cytomegalovirus immunoglobulin (Ig) M, herpes sim-
plex virus IgM, and viral serology for hepatitis A, B, and C
were negative. Epstein-Barr virus IgM was under 1:10 (nor-
mal range under 1:10) and Epstein-Barr virus IgG was 1:160
(normal range under 1:10). Bacterial and viral cultures of
blood, urine, and stool were negative. On the following day,
she developed an acute respiratory distress syndrome that
required mechanical ventilation. A bone marrow aspiration
and biopsy showed many histiocytes and obvious hemophago-
cytic histiocytes (20% of total histiocytes) (Fig. 1). Fine-nee-
dle aspiration biopsy of lymph nodes revealed paracortical
necrotizing lesions with typical features of Kikuchi’s disease
(Fig. 2, 3). 
Intravenous immunoglobulin (0.4 g/kg/day for 5 days) and
methylprednisolone (1 g/d for 3 days) were administered. There
were no further seizure attack any more and we did not pre-
scribed any antiepileptic drug. The clinical symptoms and
signs improved gradually. On day 3, she was administered
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Hemophagocytic Syndrome Associated with Kikuchi's Disease
A 13-yr-old female was admitted to our hospital with fever, seizure, and cervical lym-
phadenopathy. Laboratory data showed pancytopenia, elevation of serum transam-
inase, lactate dehydrogenase, triglyceride, and ferritin levels. Lymph node biopsy
revealed features of Kikuchi’s disease and there were signs of histiocytosis and
hemophagocytic phenomenon in bone marrow. She recovered after treatment with
intravenous immunoglobulin and corticosteroids therapy. Hemophagocytic syndrome
can be associated with Kikuchi’s disease especially in childhood and seems to have
a less aggressive clinical course and better prognosis.
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with etoposide (150 mg/m2), which was discontinued due to
subsequent pancytopenia (white blood cell count 410/ L;
hemoglobin 9.2 g/dL; platelets 19,000/ L on day 12). We
continued supportive care and prescribed oral dexamethasone
(10 mg/m2/day every 8 hr for 2 weeks, followed by 7.5 mg/m2/
day every 8 hr for 2 weeks, 5 mg/m2/day every 8 hr for 2 weeks,
and 2.5 mg/m2/day every 8 hr for 1 weeks) and bactrim (5 mg/
kg in 2 divided doses, three times per week) with dramatic re-
sponse. She required mechanical ventilation for 7 days. There
was complete resolution of the hemophagocytic syndrome with-
in 1.5 months and no evidence of disease recurrence during
the following 8 months.
DISCUSSION
Diagnosis of hemophagocytic syndrome can be made with
fever of unknown etiology for 7 or more days, unexplained
cytopenia affecting at least 2 cell lines, abnormal liver func-
tion tests, disseminated intravascular coagulopathy, and bone
marrow that contains greater than 3% histiocytes undergo-
ing hemophagocytosis. Clinical severity ranges from complete
recovery to rapid deterioration. The mortality rate is 20-
42% (10).
Our patient had necrotizing lymphadenitis followed by ful-
minant hemophagocytic syndrome. Eight cases of hemophago-
cytic syndrome combined with necrotizing lymphadenitis have
been reported in the literature thus far (3-9). Four patients
aged from 14 to 17 yr and three were Asians. Two patients had
underlying systemic lupus erythematosus and one patients was
pregnant. Six patients recovered after treatment with corticos-
teroids with or without intravenous immunoglobulin.
Kikuchi’s disease is usually self-limited and supportive treat-
ment alone is sufficient for the disease. The treatment and prog-
nosis of childhood Kikuchi’s disease associated with hemoph-
gocytic syndrome remain unclear. According to our review of
the literature, childhood Kikuchi’s disease is more frequently
associated with hemophagocytic syndrome and seems to have
a less aggressive course and better prognosis than the adult
Fig. 1. Bone marrow aspirate shows histiocytes engulfing erythro-
cytes (Wright stain, ×1,000).
Fig. 2. Low power view of necrotizing lymphadenitis shows necro-
sis with infiltration of numerous lymphocytes and histiocytes (H&E
stain, ×40).
Fig. 3. High power view of necrotizing lymphadenitis shows numer-
ous apoptotic bodies (H&E stain, ×400).594 Y.M. Kim, Y.J. Lee, S.O. Nam, et al.
counterpart. 
Our case shows that childhood hemophagocytic syndrome
can be associated with Kikuchi’s disease and assume a relative-
ly benign course. Administration of intravenous immunoglob-
ulin and corticosteroids may be the treatment of choice of
hemophagocytic syndrome associated with Kikuchi’s disease
and may provide satisfactory results. Chemotherapy, such as
etoposide-containing regimen, can be reserved for those who
fail to respond to intravenous immunoglobulin and corticos-
teroids.
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